|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$552,983
|
$110,596
|
Hickstein, Dennis
|
CCR (NCI)
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S1
|
$35,000
|
$2,450
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S2
|
$5,000
|
$350
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-33
|
$1,795,225
|
$125,666
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-20
|
$1,808,081
|
$361,616
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
WHI Hormones and Gynecologic Cancers Study
|
ZIA CP010126-10538
|
$56,209
|
$28,104
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
Vitamin D Pooling Project
|
ZIA CP010195-10436
|
$75,891
|
$12,142
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Virginia Mason Community Clinical Oncology Program
|
2U10CA035192-27A1
|
$569,700
|
$45,576
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-21S1
|
$50,000
|
$3,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-21
|
$490,679
|
$29,441
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vascular Leukocytes influence the tumor microenvironment
|
5R01CA124515-06
|
$312,204
|
$312,204
|
Conejo-Garcia, Jose
|
WISTAR INSTITUTE
|
|
Validation of an Antibody Test for Early Diagnosis of Ovarian Cancer
|
1R01CA160541-01
|
$315,400
|
$315,400
|
TAINSKY, MICHAEL
|
WAYNE STATE UNIVERSITY
|
|
Validating Cancer Risk Models: a Pilot Study to Evaluate Cost-efficient Methods
|
5R03CA150136-02
|
$80,078
|
$40,039
|
Whittemore, Alice
|
STANFORD UNIVERSITY
|
|
VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER
|
5R01CA131400-03
|
$336,129
|
$336,129
|
Springett, Gregory
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Vaccine-Dac/Bev Combinatorial Therapy in Ovarian Cancer
|
1R21CA156224-01A1
|
$348,000
|
$348,000
|
COUKOS, GEORGE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$230,674
|
$23,067
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$269,119
|
$26,911
|
Hodge, James
|
CCR (NCI)
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S1
|
$74,970
|
$750
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S2
|
$139,926
|
$1,399
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-38
|
$4,555,705
|
$45,557
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Utrasensitive bioassays using palladium catalyzed chemical amplification
|
1R43CA159478-01
|
$199,996
|
$149,997
|
Lelental, Mark
|
BIOFORMATIX, INC.
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-23
|
$2,179,856
|
$87,194
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using mouse models to probe the relationship of oncogenesis to development and o
|
5U01CA105492-08
|
$743,710
|
$245,424
|
HOLLAND, ERIC
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Use of nanogels to target delivery of siRNA to cancer cells in mice
|
1R21CA155479-01
|
$240,470
|
$240,470
|
McDonald, John
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
2P30CA014089-36
|
$6,160,984
|
$184,830
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S1
|
$50,000
|
$1,500
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S2
|
$244,500
|
$7,335
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S3
|
$74,923
|
$2,248
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer
|
5R01CA108990-07
|
$565,354
|
$565,354
|
LOKSHIN, ANNA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-27
|
$1,400,911
|
$112,073
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
2P30CA036727-25
|
$1,504,111
|
$15,041
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-25S1
|
$74,642
|
$746
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-27
|
$2,137,632
|
$21,376
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S1
|
$49,474
|
$1,979
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S2
|
$75,000
|
$3,000
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-07S3
|
$140,000
|
$5,600
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-07
|
$1,934,104
|
$77,364
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S2
|
$50,000
|
$2,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S3
|
$5,694,947
|
$227,798
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-24
|
|
$0
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding the origin and pathogenesis of epithelial ovarian cancer
|
1F32CA159523-01
|
$53,042
|
$53,042
|
Kim, Jaeyeon
|
BAYLOR COLLEGE OF MEDICINE
|
|
U10 Full Member Application Affiliated with SWOG
|
5U10CA105409-08
|
$325,684
|
$3,257
|
Kim, Edward
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer
|
5U01CA151461-02
|
$433,830
|
$216,915
|
O'HALLORAN, THOMAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Tumor Suppressor Protein, p53
|
ZIA BC 005599
|
$323,127
|
$161,563
|
Appella, Ettore
|
CCR (NCI)
|
|
Tumor Banking for the Southwest Oncology Group
|
3U24CA114748-05S2
|
$124,541
|
$12,454
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Tumor -Targeting Chemotherapeutic Agents
|
5R01CA103314-20
|
$314,565
|
$72,350
|
OJIMA, IWAO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Treatment of Chemotherapy-Resistant Human Ovarian Cancer by Administration of CPE
|
5R01CA122728-04
|
$329,744
|
$329,744
|
SANTIN, ALESSANDRO
|
YALE UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-12S1
|
$75,000
|
$2,250
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-12
|
$2,947,311
|
$88,419
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Transforming growth factor beta signaling pathways
|
5R01CA055536-20
|
$195,663
|
$48,916
|
HOWE, PHILIP
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
Total relevant funding to Ovarian Cancer for this search: $110,825,125
|